The results obtained with the proposed method are in excellent agreement with those provided by the official method, but with a shorter analysis time, lower sample and reagent consumption and less analyst involvement.
In conclusion, the multiplex immunoassay can offer higher sample throughput, less sample consumption, shorter assay time and lower cost than the traditional parallel single-analyte immunoassay.
This method provides a new avenue for high throughput screen of mycotoxins due to the advantages of simple instrument, low sample consumption, short assay times, and lower detection costs per assay.
Miniaturization of DMS to the size of a palm portable device using state-of-art microelectromechanical systems significantly lowers power consumption, decreases analysis times (sub milliseconds) and reduces sample consumption.
The development of novel, miniaturized sensing systems is driven by the demand for better and faster chemical measurements with lower power consumption and smaller sample sizes.
Compared to normal flow injection analysis, the rFIA method is superior due to its lower reagent consumption, less dispersion of sample, as well as higher sensitivity.
Compared with the normal indophenol blue (off-line) method, the proposed method was superior due to its lower reagent consumption, greater convenience, higher sample throughput, wider linear range (10 nmol·L− 1 to 30 μmol·L− 1), as well as higher sensitivity.
This is supported by the slightly lower hydrogen consumption registered for the main peak of the A6 sample (5.3 mmol H2/g) with respect to the A2 sample (5.5 mmol H2/g).
The lower hydrogen consumption of this peak indicates that both samples contained more Co3+/Co2+ than Co4+, in agreement with the above discussion.
